How much is Avail Medsystems worth in 2026?

Avail Medsystems has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Avail Medsystems raised?

Avail Medsystems has raised N/A in total funding across 1 funding rounds.

Avail Medsystems

Other Healthcare Technology Systems

Avail Medsystems valuation and funding history | Last updated: October 7, 2020 | 1 funding rounds

Current Valuation

N/A

As of October 7, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$100.0M

Last Funding

Oct 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 7, 2020	Early Stage VC (Series B)	$100.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Avail Medsystems is currently valued at N/A as of October 7, 2020.

Track Avail Medsystems Valuation Updates

Get notified when Avail Medsystems raises new funding or valuation changes

Explore More Data

Detailed analysis for Avail Medsystems

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Avail Medsystems's valuation history, funding rounds, and growth metrics.

No credit card required

What is Avail Medsystems Worth in 2026?

Avail Medsystems is a leading private company in the Other Healthcare Technology Systems sector. Track Avail Medsystems's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Avail Medsystems Valuation is Determined

Private company valuations like Avail Medsystems's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.